Rheumatology投稿须知

期刊简介

《Rheumatology》是由Oxford University Press出版社于1999年创办的英文国际期刊（ISSN: 1462-0324，E-ISSN: 1462-0332），该期刊长期致力于风湿病学领域的创新研究，主要研究方向为风湿病学-医学。作为SCIE收录期刊（JCR分区 Q1，中科院 2区），本刊采用OA未开放获取模式（OA占比0.2640...%），以发表风湿病学领域等方向的原创性研究为核心（研究类文章占比92.21%%）。凭借严格的同行评审与高效编辑流程，期刊年载文量精选控制在488篇，确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库，为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Rheumatology审稿周期约为约2月。该刊近年未被列入国际预警名单，年发文量约488篇，录用竞争适中，主题需确保紧密契合医学前沿。投稿策略提示：避开学术会议旺季投稿以缩短周期，语言建议专业润色提升可读性。

医学大类学科
English 出版语言
否是否预警
SCIE 期刊收录
488 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊	综述期刊	大类学科	小类学科
是	否	医学 2区	RHEUMATOLOGY 风湿病学 2区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊	综述期刊	大类学科	小类学科
是	否	医学 1区	RHEUMATOLOGY 风湿病学 2区

JCR分区

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：RHEUMATOLOGY	SCIE	Q1	9 / 57	85.1%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：RHEUMATOLOGY	SCIE	Q1	9 / 57	85.09%

CiteScore

SJR

SNIP

CiteScore 排名

CiteScore：9.4

SJR：1.721

SNIP：1.544

学科类别	分区	排名	百分位
大类：Medicine 小类：Pharmacology (medical)	Q1	25 / 272	90%
大类：Medicine 小类：Rheumatology	Q1	8 / 73	89%

期刊发文

Early onset is an indication of the severity of DADA2 disease
Author: Zhao, Xiaozhen; Zhang, Junmei; Li, Caifeng; Kuang, Weiying; Deng, Jianghong; Tan, Xiaohua; Li, Chao; Li, Shipeng; Wang, Jiang

Journal: RHEUMATOLOGY. 2023; Vol. 62, Issue 2, pp. 969-976. DOI: 10.1093/rheumatology/keac233
Cancer occurrence after SLE: effects of medication-related factors, disease-related factors and survival from an observational study
Author: Zhao, Qing; Liu, Huazhen; Yang, Wenfang; Zhou, Ziyue; Yang, Yiying; Jiang, Xu; Yang, Huaxia; Zhang, Fengchun

Journal: RHEUMATOLOGY. 2023; Vol. 62, Issue 2, pp. 659-667. DOI: 10.1093/rheumatology/keac316
DNA from macrophages induces fibrosis and vasculopathy through POLR3A/STING/type I interferon axis in systemic sclerosis
Author: Liu, Chaofan; Tang, Jiaxuan; Luo, Wei; Liu, Shiying; Sun, Xiaolei; Hong, Wenxuan; Zhou, Xing; Lu, Jinghao; Li, Ming; Zhu, Lubing

Journal: RHEUMATOLOGY. 2023; Vol. 62, Issue 2, pp. 934-945. DOI: 10.1093/rheumatology/keac324
TOX promotes follicular helper T cell differentiation in patients with primary Sjogren's syndrome
Author: Liu, Suying; Yang, Yanlei; Zeng, Liuting; Wang, Li; He, Chengmei; Chen, Zhilei; Sun, Jinlei; Lyu, Taibiao; Wang, Mu; Chen, Hua; Zhang, Fengchun

Journal: RHEUMATOLOGY. 2023; Vol. 62, Issue 2, pp. 946-957. DOI: 10.1093/rheumatology/keac304
Genetic contributions to female gout and hyperuricaemia using genome-wide association study and polygenic risk score analyses
Author: Lin, Chien-Yu; Chang, Ya-Sian; Liu, Ting-Yuan; Huang, Chung-Ming; Chung, Chin-Chun; Chen, Yu-Chia; Tsai, Fuu-Jen; Chang, Jan-Gowth; Chang, Shun-Jen

Journal: RHEUMATOLOGY. 2023; Vol. 62, Issue 2, pp. 638-646. DOI: 10.1093/rheumatology/keac369
Evaluating the value of superoxide dismutase in anti-MDA5-positive dermatomyositis associated with interstitial lung disease
Author: Huang, Wenhan; Chen, Dandan; Wang, Zhongjie; Ren, Feifeng; Luo, Lei; Zhou, Jun; Huang, Dongmei; Tian, Mengxue; Chen, Hong; Tang, Lin

Journal: RHEUMATOLOGY. 2023; Vol. 62, Issue 3, pp. 1197-1203. DOI: 10.1093/rheumatology/keac429
Predictors and prognostic stratification for lupus low disease activity state: results from a prospective clinical trial
Author: Zhang, Kai; An, Yuan; Zhao, Peng; Huang, Bo; Wang, Yifan; Zhou, Xingyu; Cheng, Gong; Xing, Xiaoyan; Wang, Naidi; Feng, Ruiling; Yu, Siyue; Li, Min; He, Jing; Li, Zhanguo

Journal: RHEUMATOLOGY. 2023; Vol. 62, Issue 3, pp. 1153-1161. DOI: 10.1093/rheumatology/keac419
Case Report: Tofacitinib as a possible treatment for arthritis in an APDS2 patient
Author: Sun, Boyuan; Zhou, Shuang; Yang, Huaxia; Zhou, Jiaxin; Leng, Xiaomei; Zhang, Wen; Zeng, Xiaofeng

Journal: RHEUMATOLOGY. 2023; Vol. 62, Issue 3, pp. E39-E41. DOI: 10.1093/rheumatology/keac436

Rheumatology

风湿病学

期刊简介

投稿提示

中科院分区

JCR分区

CiteScore

期刊发文

怎样选择期刊

投稿相关问题

投稿后咨询